Skip to main content
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
Home
Browse by Topic
Issues
Online First
Latest Issue
Issue Archive
Special Issues
PSS Guide
Index
Introduction
Special Series
OFS Summit
Conference Correspondent
SABCS 2023 - HER2+ MBC
SABCS 2023 - HR+/HER2- MBC
ESMO 2023 - Small Cell Lung Cancer
ASCO 2023 - Breast Cancer
Monthly Minutes
Gastrointestinal Cancer
Lung Cancer
Multiple Myeloma
Women's Health
Multimedia
All Videos
Interview with the Innovators
Rapid Reactions
Webinars
Subscribe
ASH 2017 Highlights
Survey Highlights Need for Improved Patient–Provider Communication and Symptom Management
By
Chase Doyle
ASH 2017 Highlights
March 2018, Vol 8, No 3
Patients with chronic myeloid leukemia (CML) may be living longer thanks to improved therapies, but the results of a new study suggest that they are burdened by ongoing symptoms and treatment side effects.
Read More ›
ASH Recaps “Phenomenal” Year for Acute Myeloid Leukemia Drug Approvals
ASH 2017 Highlights
February 2018, Vol 8, No 2
Read More ›
CAR T-Cell Therapy Makes Significant Inroads in Lymphoma: Kymriah and Yescarta Show Durable Remissions
ASH 2017 Highlights
,
Hematologic Malignancies
,
Lymphoma
February 2018, Vol 8, No 2
Read More ›
CAR T-Cell Therapy Shows “Impressive” Results in Multiple Myeloma
ASH 2017 Highlights
,
Hematologic Malignancies
,
Multiple Myeloma
February 2018, Vol 8, No 2
Read More ›